CSL Limited
OTC: CMXHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gordon Naylor DipCompSc
- Employees
- 32,698
- Headquarters
- Melbourne, Australia
- IPO year
- 2005
- Market cap
- $35.3B
- Website
- https://www.csl.com.au
Loading CMXHF…
Loading profile data…Frequently asked questions about CMXHF
What does CSL Limited (CMXHF) do?
CSL Limited is a global biopharmaceutical enterprise engaged in the discovery, development, production, marketing, and distribution of a wide array of medicinal and related products. Its operations span key markets including Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company's activities are organized...
Where does CMXHF trade?
CSL Limited (CMXHF) trades on the Other OTC.
What sector is CMXHF in?
CSL Limited (CMXHF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CSL Limited?
Gordon Naylor DipCompSc is the chief executive officer of CSL Limited (CMXHF).
Where is CSL Limited headquartered?
CSL Limited is headquartered in Australia.
Does CMXHF pay a dividend?
Yes — CSL Limited (CMXHF) paid a trailing twelve-month dividend of USD 2.92 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CMXHF go public?
CSL Limited (CMXHF) completed its initial public offering in 2005.